Responses
Letter
ITPA genotyping test does not improve detection of Crohn’s disease patients at risk of azathioprine/6-mercaptopurine induced myelosuppression
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 18 April 2016
- Published on: 18 April 2016ITPA genotyping is not predictive for the development of side effects in AZA treated IBD patientsShow More
J.M. van Dieren, A.J. van Vuuren, J.G. Kusters, E.E.S. Nieuwenhuis, E.J...
Conflict of Interest:
None declared.